Annie Yessaian, MD

Clinical Assistant Professor of Obstetrics & Gynecology (Clinician Educator)

Director of the Gynecology/Oncology Outreach Program

Image of Annie Yessaian, MD
Is this your profile? Click to edit

Overview

Dr. Yessaian graduated from the University of Baghdad Medical School, Iraq in 1989 with high honors. She then further trained in a rotating internship for two years in Baghdad. Dr. Yessaian then joined the residency training program in general surgery at Maimonides Medical Center-Brooklyn NY, where she also received four additional years of obstetrics & gynecology training. She completed her residency in 1998, receiving the award of “Best Chief Resident of the Year. Dr. Yessaian received further training in a research fellowship in molecular biology at Memorial Sloan Kettering Cancer Center, studying platinum resistance in ovarian cancer. She then joined the gynecologic oncology fellowship program at UC Irvine for four more years, where her research areas included angiogenesis in ovarian cancer. Dr. Yessaian received the Society of Gynecologic Oncologist award for best paper presented by a fellow in 2002. In 2004, Dr. Yessaian joined USC as an Assistant professor of clinical Ob-gyn, Gynecologic Oncology. She practices the full scope of gynecological oncology from minimally invasive robotic and fertility sparing surgery, to the ultra-radical surgeries and including chemotherapy, immunotherapy and clinical trials enrollment.

Publications

  • Temporal trends of failure-to-rescue following perioperative complications in vulvar cancer surgery in the United States. Gynecol Oncol. 2023 10; 177:1-8.. View in PubMed
  • Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer. Gynecol Oncol. 2023 06; 173:49-57.. View in PubMed
  • Our Space of Morrow. Int J Gynecol Cancer. 2022 Dec 05; 32(12):1634.. View in PubMed
  • Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2022 Aug; 275:91-96.. View in PubMed
  • Side-to-end reanastomosis after low-anterior resection (STELAR): Outcomes, feasibility, and description of procedure performed by a gynecologic oncology service. J Surg Oncol. 2022 Sep; 126(3):563-570.. View in PubMed
  • Population-level uptake of neoadjuvant chemotherapy for stage IVB endometrial cancer. Gynecol Oncol. 2022 06; 165(3):428-436.. View in PubMed
  • Trends and characteristics of ovarian conservation at hysterectomy for young women with cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2022 Jun; 273:59-64.. View in PubMed
  • Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery. Radiat Oncol. 2021 Aug 25; 16(1):162.. View in PubMed
  • Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery. Radiat Oncol. 2021 Jun 29; 16(1):123.. View in PubMed
  • Implementation of multidisciplinary practice change to improve outcomes for women with placenta accreta spectrum. Eur J Obstet Gynecol Reprod Biol. 2020 Mar; 246:194-196.. View in PubMed